Daniel Schneider
Director Ejecutivo en PHOTOCURE ASA .
Fortuna: 497 808 $ al 30/04/2024
Cargos activos de Daniel Schneider
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| PHOTOCURE ASA | Director Ejecutivo | 01/11/2018 | - |
| Presidente | 01/11/2018 | - |
Historial de carrera de Daniel Schneider
Antiguos cargos conocidos de Daniel Schneider.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABLYNX | Director Ejecutivo | - | - |
Formación de Daniel Schneider.
| University of Washington | Masters Business Admin |
| St. Louis University | Undergraduate Degree |
Estadísticas
Internacional
| Noruega | 2 |
| Estados Unidos | 2 |
| España | 2 |
Operativa
| Chief Executive Officer | 2 |
| President | 1 |
| Masters Business Admin | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHOTOCURE ASA | Health Technology |
| Empresas privadas | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
- Bolsa de valores
- Insiders
- Daniel Schneider
- Experiencia
